Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rectal Neoplasms 1Inflammation 1Carcinoma, Renal Cell 1Acute Kidney Injury 1

Interventions

Nivolumab 143pembrolizumab 129Sunitinib 127Bevacizumab 71Everolimus 70Sorafenib 68cabozantinib 64Ipilimumab 61pazopanib 58Axitinib 57aldesleukin 51Magnetic Resonance Spectroscopy 43Cyclophosphamide 40Interleukin-2 38lenvatinib 36Radiosurgery 36Specimen Handling 33Interferon-alpha 32atezolizumab 29belzutifan 24temsirolimus 23Gemcitabine 23fludarabine phosphate 22Radiotherapy 18Interferon alpha-2 18Biopsy 18fludarabine 17durvalumab 17avelumab 17Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Renal Cell × Ischemic Preconditioning × Clear all
NCT07497958 2026-03-27

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Sun Yat-sen University

Phase NA Not yet recruiting
174 enrolled
Genitourinary

Carcinoma, Renal Cell, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon âš¡